Comparação entre troponina I cardíaca e CK-MB massa em síndrome coronariana aguda sem supra de ST

Santos, Elizabete Silva dos; Baltar, Valéria Troncoso; Pereira, Marcos Paulo Torres; Minuzzo, Luiz; Timerman, Ari; Avezum, Álvaro

doi:10.1590/s0066-782x2011005000016

Cited by 11 publications

(1 citation statement)

References 26 publications

(24 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…These are released by damaged heart tissue. 49 The present research also entails appraisal of the cardio-protective role of F. xanthoxyloides against CCl 4 mediated cardiac trauma. CCl 4 induced myocardial injuries, which aer oral administration of FXE, not only levelled out the reduced antioxidants, but also protected tissues from lipid peroxidation.…”

Section: Discussionmentioning

confidence: 99%

The protective potential of aFraxinus xanthoxyloidesethyl acetate fraction against CCl₄-induced oxidative stress in the cardiac tissue of rats

et al. 2020

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 99%

The protective potential of aFraxinus xanthoxyloidesethyl acetate fraction against CCl₄-induced oxidative stress in the cardiac tissue of rats

et al. 2020

View full text Add to dashboard Cite

show abstract

Protective effect of quercetin and/or l-arginine against nano-zinc oxide-induced cardiotoxicity in rats

et al. 2013

View full text Add to dashboard Cite

A Narrative Review and Expert Panel Recommendations on Dyslipidaemia Management After Acute Coronary Syndrome in Countries Outside Western Europe and North America

et al. 2020

View full text Add to dashboard Cite

Patients who have experienced an acute coronary syndrome (ACS) are at very high risk of recurrent atherosclerotic cardiovascular disease (CVD) events. Dyslipidaemia, a major risk factor for CVD, is poorly controlled post ACS in countries outside Western Europe and North America, despite the availability of effective lipid-modifying therapies (LMTs) and guidelines governing their use. Recent guideline updates recommend that low-density lipoprotein cholesterol (LDL-C), the primary target for dyslipidaemia therapy, be reduced by C 50% and to \ 1.4 mmol/L (55 mg/dL) in patients at very high risk of CVD, including those with ACS. The high prevalence of CVD risk factors in some regions outside Western Europe and North America confers a higher risk of CVD on patients in these countries. ACS onset is often earlier in these patients, and they may be more challenging to treat. Other barriers to effective dyslipidaemia control include low awareness of the value of intensive lipid lowering in patients with ACS, physician non-adherence to guideline recommendations, and lack of efficacy of currently used LMTs. Lack of appropriate pathways to guide follow-up of patients with ACS post discharge and poor access to intensive medications are important factors limiting Digital Features To view digital features for this article go to

show abstract

Comparação entre troponina I cardíaca e CK-MB massa em síndrome coronariana aguda sem supra de ST

Abstract: Background: There is uncertainty as to the comparative prognostic value between cardiac troponin I (cTnI) and CK-MB in acute coronary syndrome (ACS).

Cited by 11 publications

References 26 publications

The protective potential of aFraxinus xanthoxyloidesethyl acetate fraction against CCl₄-induced oxidative stress in the cardiac tissue of rats

The protective potential of aFraxinus xanthoxyloidesethyl acetate fraction against CCl₄-induced oxidative stress in the cardiac tissue of rats

Protective effect of quercetin and/or l-arginine against nano-zinc oxide-induced cardiotoxicity in rats

A Narrative Review and Expert Panel Recommendations on Dyslipidaemia Management After Acute Coronary Syndrome in Countries Outside Western Europe and North America

Contact Info

Product

Resources

About

Comparação entre troponina I cardíaca e CK-MB massa em síndrome coronariana aguda sem supra de ST

Abstract: Background: There is uncertainty as to the comparative prognostic value between cardiac troponin I (cTnI) and CK-MB in acute coronary syndrome (ACS).

Cited by 11 publications

References 26 publications

The protective potential of aFraxinus xanthoxyloidesethyl acetate fraction against CCl4-induced oxidative stress in the cardiac tissue of rats

The protective potential of aFraxinus xanthoxyloidesethyl acetate fraction against CCl4-induced oxidative stress in the cardiac tissue of rats

Protective effect of quercetin and/or l-arginine against nano-zinc oxide-induced cardiotoxicity in rats

A Narrative Review and Expert Panel Recommendations on Dyslipidaemia Management After Acute Coronary Syndrome in Countries Outside Western Europe and North America

Contact Info

Product

Resources

About

The protective potential of aFraxinus xanthoxyloidesethyl acetate fraction against CCl₄-induced oxidative stress in the cardiac tissue of rats

The protective potential of aFraxinus xanthoxyloidesethyl acetate fraction against CCl₄-induced oxidative stress in the cardiac tissue of rats